Literature DB >> 15337448

Synthesis of novel ammonium and selenonium ions and their evaluation as inhibitors of UDP-galactopyranose mutase.

Natacha Veerapen1, Yue Yuan, David A R Sanders, B Mario Pinto.   

Abstract

The syntheses of two ammonium salts of 1,4-dideoxy-1,4-imino-d-galactitol containing erythritol sulfate side chains are described. The parent compound is a known inhibitor of the enzyme UDP-galactopyranose mutase (UDP-galactopyranose furanomutase, E.C. 5.4.99.9), which is responsible for the conversion of UDP-galactopyranose into UDP-galactofuranose and is presumably protonated in its active form. The side chain was chosen because it is present in a known sulfonium ion alpha-glucosidase inhibitor, salacinol. The syntheses of the selenonium analogues derived from 1,4-dideoxy-1,4-seleno-d-galactitol are also described. The synthetic strategy in the syntheses of all four salts involved the nucleophilic attack of a protected derivative of the alditol at the least hindered carbon of 2,4-O-benzylidene d- or l-erythritol-1,3-cyclic sulfate to give adducts that were subsequently deprotected. The importance of different protecting groups used in the various syntheses is also highlighted. Enzyme inhibition assays carried out on these compounds, and the corresponding sulfonium ions synthesized previously, show that they are poor inhibitors of UDP-galactopyranose mutase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337448     DOI: 10.1016/j.carres.2004.07.012

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  8 in total

1.  Carboxylate Surrogates Enhance the Antimycobacterial Activity of UDP-Galactopyranose Mutase Probes.

Authors:  Valerie J Winton; Claudia Aldrich; Laura L Kiessling
Journal:  ACS Infect Dis       Date:  2016-06-29       Impact factor: 5.084

2.  Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite.

Authors:  Emily C Dykhuizen; Laura L Kiessling
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

3.  Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations.

Authors:  Sherif T S Hassan; Miroslava Šudomová; Kateřina Berchová-Bímová; Shanmugaraj Gowrishankar; Kannan R R Rengasamy
Journal:  J Clin Med       Date:  2018-08-20       Impact factor: 4.241

4.  A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases.

Authors:  Miroslava Šudomová; Mohammad Ali Shariati; Javier Echeverría; Ioana Berindan-Neagoe; Seyed Mohammad Nabavi; Sherif T S Hassan
Journal:  Mar Drugs       Date:  2019-11-14       Impact factor: 5.118

5.  Sugar nucleotide recognition by Klebsiella pneumoniae UDP-D-galactopyranose mutase: fluorinated substrates, kinetics and equilibria.

Authors:  James C Errey; Maretta C Mann; Shirley A Fairhurst; Lionel Hill; Michael R McNeil; James H Naismith; Jonathan M Percy; Chris Whitfield; Robert A Field
Journal:  Org Biomol Chem       Date:  2009-01-23       Impact factor: 3.876

Review 6.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.

Authors:  Cinzia Colombo; Olimpia Pitirollo; Luigi Lay
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

7.  Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies.

Authors:  Christopher Llynard D Ortiz; Gladys C Completo; Ruel C Nacario; Ricky B Nellas
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 8.  N5 Is the New C4a: Biochemical Functionalization of Reduced Flavins at the N5 Position.

Authors:  Brett A Beaupre; Graham R Moran
Journal:  Front Mol Biosci       Date:  2020-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.